Literature DB >> 26420698

Upper gastrointestinal bleed associated with cholinesterase inhibitor use.

Khoon-Sheng Kok1, Yoon Loke2, Jo Southgate1.   

Abstract

An 86-year-old man was admitted with a 3-day history of melaena and syncope. He was haemodynamically compromised and anaemic on presentation. His only medical history was mild Alzheimer's disease diagnosed 6 months prior. For this, he was on donepezil, a cholinesterase inhibitor (ChEI), with a recent dose increase 3 months earlier. After fluid resuscitation with packed red cells, an endoscopy was performed, which showed an acute duodenal ulcer. This was treated with a high-dose proton pump inhibitor. The patient recovered well and was discharged on donepezil with the addition of a gastro-protective proton pump inhibitor. In view of other absent risk factors of upper gastrointestinal haemorrhage, donepezil was the likely causative agent. ChEIs are associated with frequent side effects and increased hospitalisation due to central and peripheral increase in acetylcholine. With this case report, we review the literature of side effects related to ChEIs, where the mechanisms of action, complications and appropriate management are discussed. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26420698      PMCID: PMC4593249          DOI: 10.1136/bcr-2015-211859

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Authors:  C Courtney; D Farrell; R Gray; R Hills; L Lynch; E Sellwood; S Edwards; W Hardyman; J Raftery; P Crome; C Lendon; H Shaw; P Bentham
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

2.  Recurrence of upper gastrointestinal bleeding after donepezil administration.

Authors:  Evangelos Cholongitas; Chrysoula Pipili; Maria Dasenaki
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

3.  Upper gastrointestinal bleeding in elderly adults with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Authors:  Kednapa Thavorn; Tara Gomes; Ximena Camacho; Zhan Yao; David Juurlink; Muhammad Mamdani
Journal:  J Am Geriatr Soc       Date:  2014-02       Impact factor: 5.562

Review 4.  Proton pump inhibitors: potential adverse effects.

Authors:  Neena S Abraham
Journal:  Curr Opin Gastroenterol       Date:  2012-11       Impact factor: 3.287

5.  A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.

Authors:  Sudeep S Gill; Muhammad Mamdani; Gary Naglie; David L Streiner; Susan E Bronskill; Alexander Kopp; Kenneth I Shulman; Philip E Lee; Paula A Rochon
Journal:  Arch Intern Med       Date:  2005-04-11

6.  Donepezil for the treatment of agitation in Alzheimer's disease.

Authors:  Robert J Howard; Edmund Juszczak; Clive G Ballard; Peter Bentham; Richard G Brown; Roger Bullock; Alistair S Burns; Clive Holmes; Robin Jacoby; Tony Johnson; Martin Knapp; James Lindesay; John T O'Brien; Gordon Wilcock; Cornelius Katona; Roy W Jones; Julia DeCesare; Michaela Rodger
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

7.  Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Authors:  Sudeep S Gill; Geoffrey M Anderson; Hadas D Fischer; Chaim M Bell; Ping Li; Sharon-Lise T Normand; Paula A Rochon
Journal:  Arch Intern Med       Date:  2009-05-11

Review 8.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Birks
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

9.  Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.

Authors:  Laura Y Park-Wyllie; Muhammad M Mamdani; Ping Li; Sudeep S Gill; Andreas Laupacis; David N Juurlink
Journal:  PLoS Med       Date:  2009-09-29       Impact factor: 11.069

10.  Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects.

Authors:  John R Hodges
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.